A randomized, double-blind, placebo-controlled study of the safety, tolerance, and preliminary pharmacokinetics of ascending single doses of orally administered sirolimus (rapamycin) in stable renal transplant recipients

Transplantation Proceedings

Volumn 28, Issue 2, 1996, Pages 987-

  Johnson, E M ^a   Zimmerman, J ^a   Duderstadt, K ^a   Chambers, J ^a   Sorenson, A L ^a   Granger, D K ^a   Almond, P S ^a   Fryer, J P ^a   Leventhal, J R ^a   Scarola, J ^a   Matas, A J ^a   Canafax, D M ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; RAPAMYCIN;

CASE REPORT; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG HALF LIFE; DRUG SAFETY; DRUG TOLERANCE; HEADACHE; HUMAN; KIDNEY TRANSPLANTATION; ORAL DRUG ADMINISTRATION; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECIPIENT;

ADMINISTRATION, ORAL; CYCLOSPORINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; HEADACHE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; PLACEBOS; POLYENES; SIROLIMUS;

EID: 9244240732     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (0)